By: Angela Harmantas
Shares in Eli Lilly and Co (NYSE:LLY) fell 7.3% after the drugmaker said sales of its Mounjaro and Zepbound weight-loss medications grew more slowly than it...
Angela Harmantas is the Editor, North America at Proactive. She specializes in the intersection of energy, mining, finance, and healthcare, with a keen focus on topics such as AI, markets, business leaders, and ESG, particularly in the context of Africa. Angela's insights and analyses have been featured in Proactive, Proactive Investors Australia, and Proactive Investors.
Preston is the artificial intelligence that powers the Intelligent Relations PR platform. Meet Preston
Not enough data
Angela Harmantas predominantly covers press releases and investment analysis across healthcare & pharmaceutical, business & industry, and finance & economy. Her focus seems to be on reporting corporate announcements, financial results, and technological innovations within these sectors.
Given her coverage attributes, Angela would likely be interested in receiving pitches related to new product launches or pivotal studies in the healthcare sector. Additionally, she might respond well to expert commentary on investment opportunities within the industries she covers.
Pitching stories about successful business strategies or innovative technologies could also align with her areas of interest. It's important for sources reaching out to Angela to provide data-driven insights or access to reliable data that supports their pitch.
This information evolves through artificial intelligence and human feedback. Improve this profile .